Joint Laboratory by ProGenTech and China CDC

摘要

ProGenTech Limited, a life science and molecular diagnostics company based in Shanghai, China and the San Francisco Bay Area has signed a collaboration agreement with the China Center for Disease Control and Prevention (CDC) to create a joint laboratory that will focus on developing next generation molecular diagnostic systems and assays. Under the terms of the agreement, the joint laboratory will leverage ProGenTech's existing Entura instrument platform and proprietary cassettes for the developmentof an integrated molecular diagnostic system. This joint system will be specifically designed for the rapid surveillance and detection of existing and emerging pathogens identified by the CDC in China. Development of ProGenTech's first fully-automated systems for sample preparation was driven by an emphasis on affordability and usability, design concepts the company plans to carry forward into this joint effort.